Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-definition/cis) was not found.

Search biology definition cis at Google

Search biology definition cis at Yahoo

Search biology definition cis at Msn

Google
 
(Date:1/5/2009)... , MADISON, WI, January 5, 2009 -- A new calibrat...nd soil scientists calibrate their thumb and foref... Seybold and colleagues, USDA-NRCS, Lincoln, NE, w...rnal of Natural Resources and Life Sciences Educat...trength of a soil to withstand an applied stress o...
(Date:1/5/2009)... , WASHINGTON -- The engineering profession,s hig...ademy of Engineering (NAE), recognize three achiev...r; led to the widespread production of antibiotics...icula for engineers. , ROBERT H. DENNARD will ... -- a $500,000 annual award that honors engineers ...
(Date:1/5/2009)... , , CLEVELANDResearchers from Case Western Rese...nificant advancement in understanding the cause be...ions in the inner womb without any signs of an inf...hers discovered that approximately 60 percent of t...nflammations were missed by traditional culture te...
(Date:1/4/2009)... , , PITTSBURGH, Jan. 4 An international team l...researchers has identified genetic markers associa..., which appear today as an advance online publicat...chers closer to understanding the biological pathw...velopment of new treatments that specifically targ...
Breaking Biology News(10 mins):Describing soils: Calibration tool for teaching soil rupture resistance 2Developer of advanced computing memory, father of biochemical engineering, and innovative engineering educators win highest engineering honors of 2009 2Developer of advanced computing memory, father of biochemical engineering, and innovative engineering educators win highest engineering honors of 2009 3Developer of advanced computing memory, father of biochemical engineering, and innovative engineering educators win highest engineering honors of 2009 4Uncultured bacteria found in amniotic fluids of women who experience preterm births 2New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics 2New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics 3Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business 781 1Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business 781 2Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business 781 3Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business 781 4Jefferson researchers find personalized interventions key to improving colon cancer screening rates 1815 1Jefferson researchers find personalized interventions key to improving colon cancer screening rates 1815 2PharmAthene Named as Contractor in 2413 9 Million Award Notice Published by the Department of Health and Human Services 778 1Doctors Office Outreach Boosts Colon Cancer Screening 1812 1Doctors Office Outreach Boosts Colon Cancer Screening 1812 2
...ole, an easy-to-use and inexpensive drug for the t...ccording to a major study co–authored by Dr. Togas...ocrinology and Infertility, McGill University Heal...ology at the Jewish General Hospital, and Professo...y. Their findings, which are currently available i...
...oday a critical step on the path of realizing the ... As described in the April 21 issue of Cell, the r...ts coupled to DNA in mouse ES cells that help expl...y cell type. These imprints, or "signatures," appe...velopment and probably coordinate their activity i...
...e talk and also hearing the buzz of the overhead l...nversation down the hallway. To focus on the perso...qual weight to all incoming sensory information. I...e rest. , Two scientists at the Stanford Universit...sorting out how the brain accomplishes this task. ...
...s the colonial tuco-tuco fascinates biologists bec...ecies has so little genetic diversity that the sli...ave wiped it off the face of the earth long ago. Y...naged to survive for thousands of years in the har...ved a complex social structure that,s unique among...
Other Biology News:Fertility drugs given 'all-clear' in new study 2Novel molecular 'signature' marks DNA of embryonic stem cells 2Novel molecular 'signature' marks DNA of embryonic stem cells 3Stanford study of owls finds link in brain between sight and sound 2Stanford study of owls finds link in brain between sight and sound 3Ancient DNA provides clues to the evolution of social behavior 2Ancient DNA provides clues to the evolution of social behavior 3Ancient DNA provides clues to the evolution of social behavior 4
(Date:1/5/2009)...- StoryCorps, a national initiative to,document e...s, will visit,Institute on Aging,s Alzheimer,s Da...ebrate the stories of the center,s participants as...is a national independent nonprofit project in,pa...r (AFC) at the Library of,Congress. , Stor...
(Date:1/5/2009)...nneapolis, MN company specializing in point of car...lis-area primary care clinic has reduced their pat...50% after successfully implementing the mPay Gatew...he mPay Gateway solution with their largest commer...ithin 12 weeks. , Minneap...
(Date:1/5/2009)...et,s fastest-growing job site, predicts the job se...inistration,s economic initiatives. , ...-- Jobfox, the Internet,s fastest-growing career s...nds to watch in 2009. The list includes the job se...grow as a result of President-elect Barack Obama,s...
(Date:1/5/2009)...e-President of Revenue and Customer Operations at ...rmer Vice President of User Experience and Design ... Mountain View, CA (PRWEB) December 17, 200...onal genetics , announced today that it has hired ...nology worlds to serve in top management positions...
Breaking Medicine News(10 mins):Health News:StoryCorps, the National Oral History Project, Partners With San Francisco Institute on Aging 2Health News:StoryCorps, the National Oral History Project, Partners With San Francisco Institute on Aging 3Health News:Use of mPay Gateway Cuts Patient Receivables by 50% 2Health News:Use of mPay Gateway Cuts Patient Receivables by 50% 3Health News:The Obama Effect: New Job Trends to Watch in 2009 2Health News:The Obama Effect: New Job Trends to Watch in 2009 3Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 2Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 3Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 4
...caused by bacteria. It can attack any part of the ...say beginning in the 1940s with the discovery of a...ppear in the United States. However, it began to r...ed. Researchers say TB is a co-infection of HIV.Ho...
...drome) is a highly contagious and occasionally fat...he virus killed nearly 800 people in a global outb...iscovered a human antibody that blocks infection c...rchers from the Dana-Farber Cancer Institute and e...
...here is a lot of confusion about what type of diet... low carbohydrate diet, a new study shows a low fa...ght loss -- even when the amount of food is not re...s examined the effect of a 12-week low fat, high-c...
...adolescents experience depression could be abnorma...enagers tend to have a smaller hippocampus -- the ..., emotion and motivation. Researchers sampled near... half of who had been diagnosed with major depress...
Other Medicine News:
Pharmalyte, narrow range pH 4.2-4.9, 25 ml. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Immobiline for IEF and Carrier Ampholytes.
Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected.
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3
Biology Products:
...bator with microprocessor-controlled 6-sided heati...filtered CO2 inlet and fanless convection heating ...temperature and % CO2 display. Accurate IR CO2 sen...istent conditions. Sealed stainless interior and r...
ArcticTemp Upright Freezer -20C. Thick wall insulation keeps your samples colder. Reversible door with magnetic gaskets. 2 shelves and a wire basket. Heavy duty compressor with 5 year warranty.
Digital Thermostat. , Exteriorbaked enamel-on-steel. , Interiorwhite anodized aluminum. , Electronic temperature control. , Temperature -20C , Positive seal doors. , Keyed door lock. , Interi
...for routine pH, mV (ORP), relative mV and temperat...ts can be obtained when used with a temperature pr...asy one-, two- and three-point calibration with Au...ers (pH 1.68, 4.00, 7.00, 10.01 and 12.45) and Aut...
Medicine Products:
(Date:1/5/2009)...Made Simple , (PRWEB) Dec...ooth into the medical device industry is the mode...examine not only the wireless interface between de...odem, but also the interface between the device CP...vanced capabilities of today,s protocol analyzer s...
(Date:1/5/2009)...wswire-FirstCall/ -- Sangamo BioSciences,Inc. (N...er, Sangamo,s president,and CEO, will provide an ...c,development programs and an overview of the com...y, January 12, 2009 at the J.P. Morgan Healthcare,...ation will be webcast live and may be accessed via...
(Date:1/5/2009)...FirstCall/ -- Wyeth (NYSE: WYE ) announced today...are CEOs Unscripted Conference on Wednesday, Janua...for Wyeth will be Bernard Poussot, Chairman, Presi...resentation will be webcast live for investors at ... the conference. , , Wyeth is one of the world,...
(Date:1/5/2009)... Jan. 5 Baxter,Internat...: HALO ) today,announced the start of a Phase I...mmune Globulin Intravenous] 10% (IGIV), marketed a...ecombinant human hyaluronidase enzyme (rHuPH20,E...y immunodeficiency (PID).,The purpose of this cli...
Breaking Biology Technology:Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 2Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 3Sangamo BioSciences to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference 2Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients 2Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients 3Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients 4Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients 5
...ewa Valley representatives hope to score points wi... this week at the largest medical device tradeshow...uring tradeshow at the Minneapolis Convention Cent...r 7,000 medical equipment and pharmaceutical compa...de economic development and technology representat...
...tware has announced the availability of the PSP M...ation Portable owners easily move content from the...PSP Media Manager software, users can transfer vid...omputer to a Playstation Portable, via a USB-cable...at lets users back up game saves, images, videos, ...
...logies Inc. has reported financial results for th...e reported total revenue of $5.2 million and a net...30, 2005, compared to total revenue of $10.5 milli...f 2004. The company reported clinical molecular di...rter, an increase of 5% from the same period of 20...
...Jim Doyle announced a new eHealth Care Quality and...the adoption of electronic medical records in Wisc...s the power of information technology at the most ...t treatment," Doyle said in a statement, citing st...e unnecessary or redundant. "This board will devel...
Other Biology Technology:Chippewa Valley reps hope to score at Twin Cities tradeshow 2Wisconsin pushes for adoption of electronic health records 2
(Date:12/15/2008)...O, Dec. 15 Arena Pharmac...hat Ortho-McNeil-Janssen Pharmaceuticals, Inc. (Or...rst-in-human Phase 1 clinical trial of APD597, a n...targets the glucose-dependent insulinotropic recep...he GDIR was also discovered by Arena and has the p...
(Date:12/14/2008)...F LAKE, N.J., Dec. 14 Eisai Corpor....S. Food and Drug Administration (FDA) has,approv...n intravenous,sedative-hypnotic agent for monitor...ts undergoing diagnostic or therapeutic procedures...LUSEDRA be used only by persons,trained in the ad...
(Date:12/14/2008)...NY, N.J., Dec. 14 A Phase II trial...AREL (DepoBupivacaine) resulted in,significantly ...urs following,surgery, when pain is generally gre...sults of the multicenter, randomized, double-blind...ostgraduate Assembly in Anesthesiology in New York...
(Date:12/12/2008)...OVER, N.J., Dec. 12 New data from ...verolimus) may overcome resistance to,Herceptin(R...tatic breast,cancer. These results support the in... fully explore the potential of RAD001 (proposed b... Two Phase I studies were presented today during t...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 3Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 4FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 2FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 3FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 4Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 2Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 3Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 4RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 2RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 3RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 4RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 5RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 6RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial 7SXC Health Solutions to present at the 2007 UBS Global Life Sciences Conference 1810 1Longs Drugs Announces Immunization Program for the 2007 2008 Flu Season 1807 1Longs Drugs Announces Immunization Program for the 2007 2008 Flu Season 1807 2Longs Drugs Announces Immunization Program for the 2007 2008 Flu Season 1807 3Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 777 1Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 777 2Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 777 3Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 777 4Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency 28EMEA 29 for MGCD0103 for the Treatment of Hodgkin 774 1Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency 28EMEA 29 for MGCD0103 for the Treatment of Hodgkin 774 2Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency 28EMEA 29 for MGCD0103 for the Treatment of Hodgkin 774 3Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency 28EMEA 29 for MGCD0103 for the Treatment of Hodgkin 774 4
...a from XL880, Phase II data from XL999 studies,sch...ns -, SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswir...t data from clinical trials of,the company,s inves...nted at the 2007 American Society of Clinical Onco...ne 1 to 5 in Chicago,Illinois. , , -- Data fro...
...y 31, 2007 /PRNewswire-FirstCall/ -- Lev,Pharmaceu...day that,it has completed patient treatment in the...ial of C1-esterase inhibitor (C1-INH) for,heredita...d CHANGE,examined and evaluated the efficacy and ...cute HAE attacks and as,prophylactic treatment to ...
Other Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 2Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 3Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 4